Increasingly, efforts are being made to link healthcare outcomes with more efficient use of resources. The current difficult economic times and healthcare reform efforts provide incentives for specific efforts in this area. Ronald J Lagoe, of the Hospital Executive Council in Syracuse, N.Y., and colleagues, conducted a study that defined relationships between inpatient complications for urinary tract infection and pneumonia and hospital lengths of stay in three general hospitals in the metropolitan area of Syracuse, New York. Their research was published in BMC Research Notes.Â
The study used the Potentially Preventable Complications (PPC) software developed by 3M Health Information Services to identify lengths of stay for patients with and without urinary tract infection and pneumonia. The patient populations included individuals assigned to the same All Patients Refined Diagnosis Related Groups and severity of illness. The comparisons involved two nine-month periods in 2008 and 2009. The study demonstrated that patients who experienced the complications had substantially longer inpatient hospital stays than those who did not. Patients with a PPC of urinary tract infection stayed a mean of 8.9 to 11.9 days or 161 to 216 percent longer than those who did not for the two time periods. This increased stay produced 2,020 to 2,427 additional patient days. The study demonstrated that patients who experienced the complications had substantially longer inpatient hospital stays than those who did not. Patients with a PPC of pneumonia stayed a mean of 13.0 to 16.3 days or 232 to 281 percent longer than those who did not for the two time periods. This increased stay produced 2,626 to 3,456 additional patient days. Similar differences were generated for median lengths of stay.
The researchers concluded that differences in hospital stays for patients in the same APR DRGs and severity of illness with and without urinary tract infection and pneumonia in the Syracuse hospitals were substantial. The additional utilization for these complications was valued at between $2,000,000 to $3,000,000 for a three-month period. These differences in the use of hospital resources have important implications for reduction of healthcare costs among providers and payors of care.
Reference: Lagoe RJ, Johnson PE and Murphy MP. Inpatient hospital complications and lengths of stay: a short report. BMC Research Notes 2011, 4:135
The Next Frontier in Infection Control: AI-Driven Operating Rooms
Published: July 15th 2025 | Updated: July 15th 2025Discover how AI-powered sensors, smart surveillance, and advanced analytics are revolutionizing infection prevention in the OR. Herman DeBoard, PhD, discusses how these technologies safeguard sterile fields, reduce SSIs, and help hospitals balance operational efficiency with patient safety.
Targeting Uncertainty: Why Pregnancy May Be the Best Time to Build Vaccine Confidence
July 15th 2025New national survey data reveal high uncertainty among pregnant individuals—especially first-time parents—about vaccinating their future children, underscoring the value of proactive engagement to strengthen infection prevention.
CDC Urges Vigilance: New Recommendations for Monitoring and Testing H5N1 Exposures
July 11th 2025With avian influenza A(H5N1) infections surfacing in both animals and humans, the CDC has issued updated guidance calling for aggressive monitoring and targeted testing to contain the virus and protect public health.
IP LifeLine: Layoffs and the Evolving Job Market Landscape for Infection Preventionists
July 11th 2025Infection preventionists, once hailed as indispensable during the pandemic, now face a sobering reality: budget pressures, hiring freezes, and layoffs are reshaping the field, leaving many IPs worried about their future and questioning their value within health care organizations.